Article
Nasospheroids permit measurements of CFTR-dependent fluid transport.
JCI insight - 16 Nov 2017
Guimbellot Jennifer S, Leach Justin M, Chaudhry Imron G, Quinney Nancy L, Boyles Susan E, Chua Michael, Aban Inmaculada, Jaspers Ilona, Gentzsch Martina
Abstract excerpt
Expansion of novel therapeutics to all patients with cystic fibrosis (CF) requires personalized CFTR modulator therapy. We have developed nasospheroids, a primary cell culture-based model derived from individual CF patients and healthy subjects by a minimally invasive nasal biopsy. Confocal microscopy was utilized to measure CFTR activity by analyzing changes in cross-sectional area over time that resulted from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
